JonesResearch analyst Debanjana Chatterjee initiated coverage of Absci (ABSI) with a Buy rating and $9 price target Absci’s artificial intelligence-driven platform can design antibodies to ...
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on AbSci (ABSI – Research Report). The associated price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback